STOCK TITAN

Natera Announces Third Quarter 2020 Earnings Conference Call

Rhea-AI Impact
(Neutral)
Rhea-AI Sentiment
(Neutral)
Tags

SAN CARLOS, Calif., Oct. 28, 2020 /PRNewswire/ -- Natera, Inc. (NASDAQ: NTRA), a pioneer and global leader in cell-free DNA testing, today announced that it will release results for its third quarter ended September 30, 2020, after the market close on November 5, 2020. Natera will host a conference call and webcast at 1:30 p.m. PT (4:30 p.m. ET) to discuss its financial results, business activities, and financial outlook.

Earnings Conference Call Information:


Event:                         

Natera's Third Quarter 2020 Financial Results Conference Call



Date:                          

Thursday, November 5, 2020



Time:                          

1:30 p.m. PT (4:30 p.m. ET)



Live Dial-In:                

(877) 823-0171, Domestic
(617) 500-6932, International



Conference ID:          

7780257



Webcast:                    

https://edge.media-server.com/mmc/p/dpgmrrok 



A webcast replay will be available at investor.natera.com.

About Natera
Natera is a pioneer and global leader in cell-free DNA testing. The mission of the company is to change the management of disease worldwide with a focus on women's health, oncology, and organ health. Natera operates ISO 13485-certified and CAP-accredited labs certified under the Clinical Laboratory Improvement Amendments (CLIA) in San Carlos, California, and Austin, Texas. It offers proprietary genetic testing services to inform obstetricians, transplant physicians, oncologists, and cancer researchers, including biopharmaceutical companies, and genetic laboratories through its cloud-based software platform. For more information, visit natera.com. Follow Natera on LinkedIn

Contacts
Investor Relations: Mike Brophy, CFO, Natera, Inc., 650-249-9090
Media: Paul Greenland, VP of Corporate Marketing, Natera, Inc., pr@natera.com

 

Cision View original content to download multimedia:http://www.prnewswire.com/news-releases/natera-announces-third-quarter-2020-earnings-conference-call-301163217.html

SOURCE Natera, Inc.

Natera, Inc.

NASDAQ:NTRA

NTRA Rankings

NTRA Latest News

NTRA Stock Data

11.85B
116.45M
4.1%
96.19%
5.17%
Medical Laboratories
Health Care and Social Assistance
Link
United States of America
AUSTIN

About NTRA

natera is a san carlos, ca-based company that is driven by a passion for elevating the science and utility of prenatal testing. the advent of the information age has created a paradigm shift in the fields of computing and informatics. surprisingly, medical diagnostics have been slow to integrate these advances into genetic testing. until natera. from conception to delivery, natera is pioneering next-generation accuracy and reliability in preconception and prenatal genetic testing services, enabling couples to be informed about their pregnancy each step of the way. the company offers a wide range of tests from preimplantation genetic diagnosis (pgd) for ivf to breakthrough advances in the field of non-invasive prenatal testing (nipt). using advances from the human genome project and powered by sophisticated proprietary bioinformatic algorithms, natera’s comprehensive portfolio of tests, proven science, and experienced genetic counseling services deliver the most accurate results in the